JRARX
Price
$77.31
Change
+$0.53 (+0.69%)
Updated
May 8 closing price
Net Assets
22.41B
RGEBX
Price
$69.59
Change
+$0.51 (+0.74%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

JRARX vs RGEBX

Header iconJRARX vs RGEBX Comparison
Open Charts JRARX vs RGEBXBanner chart's image
Janus Henderson Research R
Price$77.31
Change+$0.53 (+0.69%)
VolumeN/A
Net Assets22.41B
American Funds Growth Fund of Amer R2E
Price$69.59
Change+$0.51 (+0.74%)
VolumeN/A
Net Assets283.8B
JRARX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JRARX vs. RGEBX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRARX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. JRARX (22.4B). JRARX (0.00) and RGEBX (0.00) have matching dividends . JRARX was incepted earlier than RGEBX: JRARX (8 years) vs RGEBX (11 years). JRARX (1.38) is less costly to investors than RGEBX (1.09). JRARX is a more actively managed with annual turnover of: 27.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than JRARX: RGEBX (250) vs JRARX (2500). JRARX annual gain was more profitable for investors over the last year : 6.14 vs. RGEBX (2.88). JRARX return over 5 years is better than : 58.39 vs. RGEBX (40.75).
JRARXRGEBXJRARX / RGEBX
Total Expense Ratio1.321.09121%
Annual Report Gross Expense Ratio1.381.09127%
Fund Existence8 years11 years-
Gain YTD-4.791-2.590185%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.4B284B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.142.88213%
Returns for 3 years59.7632.03187%
Returns for 5 years58.3940.75143%
Returns for 10 yearsN/A54.75-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDRX4.240.45
+11.87%
GoodRx Holdings
KAVL0.600.03
+4.37%
Kaival Brands Innovations Group
PNR93.531.75
+1.91%
Pentair plc
SUPV14.60N/A
N/A
Grupo Supervielle SA
BDSX0.35-0.08
-17.91%
Biodesix